WEBINARS AND EVENTS How Cancer Care Northwest Made Germline Genetic Testing Routine In Oncology Register now Speakers: Jennifer Lazzara DNP, ARNP, CGRA Breanna Roscow MS, CGC, Medical Science Liaison, Myriad Genetics Date: 11/20/2025 Time: 1 PM EST Duration: 1 hour CEU: No Germline genetic testing is one of the most powerful ways to prevent cancer and detect it earlier — but many oncology teams don’t have the capacity to implement it effectively. Despite clear clinical guidelines, most programs struggle to identify eligible patients or move them through a referral-based process. A JAMA study found that only 6.8% of eligible cancer patients undergo germline testing after diagnosis. At Cancer Care Northwest (CCNW), that story looks different. Their oncology team is not only identifying eligible patients but also closing the loop — ensuring testing actually happens. By replacing a traditional referral model with a point-of-care testing approach, CCNW has achieved a 78.3% germline testing rate — more than 11× the national average. Their success came from choosing the right tools for their team — digital workflows that helped specialists and advanced practice providers work at the top of their license, and access to genetics expertise that filled the gaps where capacity was limited. The result: a practical, scalable model that brings prevention and early detection directly into oncology care. In this session, Jennifer Lazzara, DNP, ARNP, CGRA, ARNP Supervisor at CCNW, will share how her team made this transformation possible. She’ll be joined by Breanna Roscow, MS, CGC, Medical Science Liaison | Certified Genetic Counselor at Myriad Genetics, to discuss how other oncology programs can build similar models to close the testing gap and expand access to prevention and early detection. What you'll learn: How to make germline genetic testing a seamless part of oncology workflows How to equip oncologists and APPs to deliver testing confidently at the point of care How leading oncology programs are choosing the right tools to close the loop and improve access Join us for a practical discussion about how prevention and precision can finally come together — and how your oncology team can lead the way. Register now Hear from our Speakers Jennifer Lazzara DNP, ARNP, CGRA Jennifer Lazzara is a board-certified Advanced Practice Registered Nurse with extensive experience in breast oncology, cancer genetics, and high-risk patient management. Jennifer attended the University of Utah in Salt Lake City, Utah where she received her Bachelor of Science in Nursing and her Doctor of Nursing Practice degrees. She also completed the City of Hope Intensive Course on Genetic Cancer Risk Assessment and earned her Cancer Genetic Risk Assessment Certification (CGRA) from the National Consortium of Breast Centers (NCBC). She currently works in an oncology practice in Spokane, WA. Breanna Roscow MS, CGC, Medical Science Liaison, Myriad Genetics Breanna Roscow is a certified genetic counselor with extensive clinical experience in oncology and hereditary cancer risk assessment. She is a Medical Science Liaison at Myriad Genetics, where she has spent the past five years supporting healthcare providers through scientific education and clinical collaboration. Breanna has a passion for research and genetic counselor training, and she is dedicated to advancing the field through mentorship and evidence-based practice.